Viewing Study NCT03841734


Ignite Creation Date: 2025-12-25 @ 2:37 AM
Ignite Modification Date: 2026-02-02 @ 5:39 AM
Study NCT ID: NCT03841734
Status: UNKNOWN
Last Update Posted: 2019-02-15
First Post: 2019-02-05
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of the Benefit of Early Treatment With an Endothelin Inhibitor (Bosentan) in Patients With Sudden Blindness Due to Giant Cell Arteritis: CECIBO
Sponsor: Centre Hospitalier Universitaire de Nice
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Arteritis, Giant Cell View
None Blindness and Low Vision View
Keywords: